Company intelligence / Profile preview

Elevator Ventures

Ownership: Private
Development stage: Other

Overview

Elevator Ventures does not develop drugs or therapies; it invests in early-stage and growth-stage fintech companies in Central and Eastern Europe. No clinical results or pipeline relevant to healthcare. Backed by Raiffeisen Bank International. Typical investment size ranges from €500k–€2M ($500k–$2M), focusing on Series A & B rounds. Provides capital, expertise, mentorship for startups. Portfolio includes companies outside of health/life sciences.

Industry: Investors

Beyond the preview

Go deeper on Elevator Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elevator Ventures.

Explore the full profile